Literature DB >> 12955443

[Diplopia after encircling procedure for retinal detachment].

A Langmann1, A Gruber, S Lindner, G Langmann.   

Abstract

PURPOSE: Our aim was to evaluate the frequency, duration and therapy of diplopia in primary position caused by motility disorders after retinal detachments treated only with encircling bands.
METHODS: A retrospective review is made of 264 consecutive patients.
RESULTS: At 6 months after surgery,18 (7%) out of the 264 patients had motility disorders with diplopia in primary position. In 55%, we found an esotropia and vertical deviation. For the treatment of diplopia, eight patients had prisms foils, five of whom are scheduled for surgery, six patients wear prism glasses and three patients did not return for follow up after their sight had been corrected with prisms. An operation for strabism was necessary in three cases, mainly because of hypertrophic scarring (adhesion syndrome), rather than suturing material or muscular decompensation. One patient needed eye occlusion for untreatable diplopia. The average change of refraction after the encircling procedure was -2.0 D.
CONCLUSIONS: We recommend avoiding unnecessary preparation of the muscles when placing the encircling band (without destruction of the Tenon or periorbital tissue), motility exercises after the operation and full refractive correction for sensory compensation of deviations as early as possible. In addition, antiphlogistic drugs should be used to avoid scarring and treatment with prism lenses. Removal of the encircling band does not seem to improve the motility as the disorder is mainly caused by hypertrophic scarring, neither does mitomycin C or the application of viscoelastic substances.

Entities:  

Mesh:

Year:  2003        PMID: 12955443     DOI: 10.1007/s00347-002-0748-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  25 in total

1.  Incomitant strabismus associated with instability of rectus pulleys.

Authors:  Sei Yeul Oh; Robert A Clark; Federico Velez; Arthur L Rosenbaum; Joseph L Demer
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

2.  Use of botulinum toxin in strabismus after retinal detachment surgery.

Authors:  V B Petitto; E G Buckley
Journal:  Ophthalmology       Date:  1991-04       Impact factor: 12.079

3.  Fat adherence syndrome after retinal surgery treated with amniotic membrane transplantation.

Authors:  M Yamada; K Shinoda; A Hatakeyama; S Nishina; Y Mashima
Journal:  Am J Ophthalmol       Date:  2001-08       Impact factor: 5.258

4.  Immediate postoperative muscular disturbance in retinal detachment surgery.

Authors:  G Theodossiadis; S Nikolakis; M Apostolopoulos
Journal:  Mod Probl Ophthalmol       Date:  1979

5.  Incidence of ocular motility problems following scleral buckling surgery.

Authors:  A F Spencer; C Newton; S A Vernon
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

6.  Silicone implant to extra-ocular muscles.

Authors:  A G Morales; F M Polack; A F Arata
Journal:  Br J Ophthalmol       Date:  1966-05       Impact factor: 4.638

7.  Diplopia after retinal detachment surgery.

Authors:  L Maillette de Buy Wenniger-Prick; A van Mourik-Noordenbos
Journal:  Doc Ophthalmol       Date:  1988 Oct-Nov       Impact factor: 2.379

8.  Phoria adaptation to prisms. A cerebellar-dependent response.

Authors:  D G Milder; R D Reinecke
Journal:  Arch Neurol       Date:  1983-06

9.  [Ocular motility disorders after retinal surgery].

Authors:  C A Lawin-Brüssel; B Anhalt; H Markodimitrakis
Journal:  Fortschr Ophthalmol       Date:  1991

10.  Synthetic polypeptide sleeve for strabismus surgery.

Authors:  F J Elsas; D C Gowda; D W Urry
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1992 Sep-Oct       Impact factor: 1.402

View more
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.